| 2025 | 2024 | 2023 | 2022 | |||||
|---|---|---|---|---|---|---|---|---|
| Gross margin | 231,4 € | +101.6% | -14,3 k € | +89.3% | -133,3 k € | -55.3% | -85,8 k € | |
| EBITDA | -178,0 € | +98.8% | -14,9 k € | +88.9% | -133,7 k € | -55.2% | -86,2 k € | |
| Operating profit | -178,0 € | +98.8% | -14,9 k € | +88.9% | -133,7 k € | -55.2% | -86,2 k € | |
| Profit/loss | -565,6 € | +96.3% | -15,1 k € | +88.8% | -135,0 k € | -54.3% | -87,5 k € | |
| Equity | -8,2 k € | -7.4% | -7,7 k € | -202.5% | 7,5 k € | -93.4% | 112,5 k € | |
| Total assets | 3,0 k € | -26.7% | 4,0 k € | -62.3% | 10,7 k € | -90.5% | 112,8 k € | |
| Cash | 2,3 k € | +8.6% | 2,1 k € | -71.9% | 7,4 k € | -91.5% | 87,0 k € | |
| Debts | 11,2 k € | -4.4% | 11,7 k € | +258.3% | 3,3 k € | +840.7% | 347,5 € | |
Source: Belgian Official Gazette
Private limited company · Gent · incorporated on 05/04/2022
Private limited company loss-making in the latest fiscal year. Cash position rising (+8.6%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Benebiose is a Private limited company incorporated in 2022. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Gent.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.